To explore the key active ingredients and molecular mechanisms of keluoxin in the treatment of diabetic nephropathy (DN) by network pharmacology and molecular docking methods.
The active constituents and their corresponding targets of keluoxin were obtained through the pharmacological analysis platform of traditional Chinese medicine. Disease targets related to DN were obtained by GeneCards and OMIM databases, and drug targets of DN were screened. Cytoscape software was used to map active ingredient-target network and protein-protein interaction network. Gene ontology and functional enrichment analysis of Kyoto gene and genome database were conducted on the target. Autodock Vina software was used to verify the molecular docking between the main active ingredients of keluoxin and the key targets.
Keluoxin can exert its therapeutic effect on DN by acting on 97 target genes through 57 active ingredients. There were 9 main active ingredients, which can regulate signaling pathway by influencing oxidative stress, inflammatory response, hypoxia response, metabolic regulation and cell apoptosis. Molecular docking results showed that quercetin, luteolin and calycoflavone had the strongest affinity to the key targets, which may be the core acting molecules in keluoxine.
The potential mechanism of keluoxin in the treatment of DN is multi-target and multi-pathway, among which quercetin, luteolin and calycoflavone may be the core molecules in keluoxin.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |